Skip to content

Clinical trials

Phase 3 Hepatitis C trials in Taiwan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hepatitis C Phase: Phase 3 Country / region: Taiwan Clear all

20 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20073
20081
20114
20124
20132
20142
20151
20161
20171
20191

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed17
Terminated1
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bristol-Myers Squibb7
GlaxoSmithKline3
Kaohsiung Medical University Chung-Ho Memorial Hospital3
Boehringer Ingelheim2
Debiopharm International SA2
AbbVie1
Gilead Sciences1
Human Genome Sciences Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hepatitis C20
Hepatitis C, Chronic7
Hepatitis B2
Acquired Immunodeficiency Syndrome1
Fibrosis1
HIV Infections1
Hepatitis1
Liver Diseases1
Non-alcoholic Fatty Liver Disease1
Thrombocytopenia1

Trials

Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.